Breast cancer survivor offers wisdom at Faulkner satellite center
Call 877-422-3324 today to make an appointment
Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.
Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.
Toll-Free Number866-408-DFCI (3324)
Discover the ways to give and how to get involved to support Dana-Farber.
Poet Richard Fox gains insight – and material – through cancer treatment
A family faces cancer in an unfamiliar city – with help
Choosing mastectomy or not: Studying young women's surgical choices
Jeff's targeted therapy has kept his advanced lung cancer at bay.
A brain tumor refers to the growth of abnormal cells in the tissues of the brain. Brain tumors can be benign or malignant. Learn about brain tumors and find information on how we support and care for children and teens with brain tumors before, during, and after treatment.
The Brain Tumor Center at Dana-Farber/Boston Children's Cancer and Blood Disorders Center cares for children with many different types of common and rare brain and spinal tumors, including astrocytomas, medulloblastomas, ependymoma, glioblastomas, and primitive neuroectodermal tumors (PNET).
Your child will receive care from some of the world’s most experienced pediatric brain tumor doctors and internationally recognized pediatric subspecialists.
Our team works closely together to develop a care plan that offers your child the highest possible quality of life after treatment, and takes the needs of your child and your family into account.
Children treated at the Brain Tumor Center have access to some of the most advanced diagnostics and therapies, including:
Thanks to refined surgical techniques and improved chemotherapy and radiation therapy, the majority of children with brain and spinal cord tumors are now long-term survivors. However, they may face physical, social, and intellectual challenges that require specialized care.
Learn more about our Brain Tumor Center.
Having a tumor in the brain is always a very serious matter, but today, more than half of all children diagnosed with a brain tumor will be cured of the disease. Tumors are masses of abnormal cells that grow out of control. When these tumors originate in the brain, they can be very complicated to treat because of the delicate surrounding tissue.
While all brain tumors are life-threatening, most children and adolescents who have been diagnosed with one survive into adulthood. Many of them face physical, psychological, social and intellectual challenges related to their treatment, and require ongoing care to help with school and with skills they will use throughout adulthood.
As you read on, you’ll find an overview of pediatric brain tumors. If you would like to read information about a specific type of brain tumor, click here for a list of pediatric brain tumors we treat.
Children with brain tumors are treated through the Pediatric Brain Tumor Center at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, an integrated pediatric hematology and oncology partnership between Dana-Farber Cancer Institute and Boston Children’s Hospital – and a world-renowned destination for children with malignant and non-malignant brain and spinal cord tumors.
Our pediatric neuro-oncology, neurosurgical and neurology specialists at Dana-Farber/Boston Children's offer:
Through the Stop & Shop Neuro-Oncology Outcomes Clinic at Dana-Farber Cancer Institute, your child will be able to meet with his entire care team at the same follow-up visit.
We understand how scary and overwhelming a diagnosis of a brain tumor can be. Right now, you probably have a lot of questions. What is the very best treatment for my child? What do we do next?
We’ve tried to provide some answers to those questions in the following pages, and our expert pediatric subspecialists can explain your child’s condition fully when you meet with us.
As you know, the brain is an important organ that controls a lot of what we do — voluntarily (like thinking) or involuntarily (like breathing). The brain controls thought, memory, emotion, touch, motor skills, vision, respiration, temperature, hunger and processes that regulate the body.
The brain can be divided into three main parts:
1. The cerebrum is composed of the right and left hemispheres. Its functions include:
2. The brainstem includes the midbrain, the pons, and the medulla. This area is responsible for:
3. The cerebellum is located at the back of the head. Its functions are to:
4. The spinal cord contains bundles of nerve fibers that emanate from the brain and spread out to all parts of the body. These fibers allow signals from the brain to travel to and communicate with different parts of the body.
5. To protect all of these structures, the brain and spinal cord are encased in solid bones wrapped in a layer of tissue called meninges.
6. In addition, the brain floats in a liquid called cerebral spinal fluid, which acts as a shock absorber to protect the brain. This fluid is made in small spaces within the brain, called ventricles.
7. The brain is connected to the face by twelve specific cranial nerves that control most eye, face and tongue movements.
Although we do not know for certain why one child gets brain cancer while another does not, we know that a small number of brain tumors can be related to genetics. Two things are true of all genetic conditions:
Because of this, we can look at what “causes” brain tumors in two different ways—how they occur in the body on the cellular level, and how a child comes to inherit the gene.
(Remember: your child may have a brain tumor because he has inherited certain genes from his parents, or because his genes have mutated on their own.)
On the cellular level
In each cell are long molecules called chromosomes. These contain genes that determine such things as height, hair color and the shape of our face. They also contain “control signals” that tell a cell when to divide, when to stop dividing, or when to die. Sometimes, these control signals become damaged. This damage is thought to create a mutant gene.
A mutant gene could do (at least) two things wrong:
If you have your foot stuck on the gas but your brakes still work, it’s okay because the brakes will let you stop. Similarly, cells have safeguards so that in case something goes wrong, mutant genes are not created. For most pediatric brain tumors, several safeguards must have failed, and created mutations in several genes.
Inheriting the gene
Again, these damaged genes can be created spontaneously or inherited. Everyone has two copies of each gene (one from each parent). In order for a tumor to grow, both copies of the gene must become damaged within the child’s body, or be already damaged and inherited—one from each parent.
Trying to find which genes have been mutated to allow a tumor to grow is like finding a needle in a haystack, but researchers all over the world are devoted to this task.
Tumors have been classified (named) according to a number of different principles.
The old way: Tumors used to be classified according to how they looked under the microscope (and often their location in the brain).
The new way: As researchers have come to understand more about the cellular and molecular differences between groups of tumors, the names have changed.
This is important because it means that many tumors have more than one name. To make it even more confusing, different tumors can have the same name. Make sure you know both:
How are brain tumors classified?
Dana-Farber/Boston Children's and Brigham and Women's Hospital use the World Health Organization (WHO) classification system for most pediatric brain tumors. This system incorporates:
Many pediatric brain tumors have a second important component to them after their name, which is the grade. This is an estimate of how aggressive or malignant a particular type of tumor is.
We can use glial tumors (which are also known as astrocytomas) as an example. Glial tumors come in four grades. Grade I is the lowest, meaning that these tumors tend to, on average, be less aggressive then their grade IV counterparts, which are usually highly malignant and very difficult to treat.
The grade is based on a number of factors, such as how many cells are dividing at any one time or how different the cells look from their normal counterparts.
Tumors can also be classified as benign or malignant:
Remember that all tumors of the central nervous system are dangerous. Even benign tumors can be fatal if they press on certain vital areas, or if they cannot be completely removed and continue to grow.
Each child may experience symptoms differently, and symptoms vary depending on size and location of the tumor — both in the brain and elsewhere in the central nervous system.
There is no space in the skull for anything except for the brain and its fluid. This means that any tumor, extra tissue or fluid can cause pressure on the brain.
Symptoms related to pressure on the brain can include:
Symptoms of brain tumors in the cerebellum may include:
Brain tumors in the lower part of the brain often press on the cerebellum. This may cause symptoms including:
Brain tumors in the brainstem may compress nerves and cause symptoms including:
Symptoms of brain tumors in the cerebrum may include:
Symptoms of brain tumors in the optic pathway (eyes) may include:
Symptoms of tumors in the spine (usually spreading from a tumor at a higher point on the spinal cord) may include:
It’s important to remember that the symptoms of a brain tumor may resemble other, more common conditions or medical problems. Always consult your child's physician for a diagnosis.
There are many different types of brain tumors. Learn more about types of pediatric brain tumors, including diagnosis and treatment options.
After your child is diagnosed with a brain tumor, you may feel overwhelmed with information. It can be easy to lose track of the questions that occur to you.
Lots of parents find it helpful to jot down questions as they arise – that way, when you talk to your child’s doctors, you can be sure that all of your concerns are addressed.
If your child is old enough, you may want to suggest that he write down what he wants to ask his health care provider, too.
Some of the questions you may want to ask include:
Q: Will my child be OK?
A: Today, more than half of all children diagnosed with a brain tumor will be cured of the disease. However, prognosis can vary widely based on the type of tumor, its location and whether it has spread. Your care team will talk to you in depth about your child’s unique situation.
Q: Where will my child be treated?
A: Children treated through Dana-Farber/Boston Children's receive outpatient care at the Jimmy Fund Clinic on the third floor of Dana Farber Cancer Institute. If your child needs to be admitted to the hospital, he will stay at Boston Children's Hospital. Learn more about our treatment facilities.
Q: What services are available to help my child and my family cope?
A: Above all, we are committed to designing a treatment plan that fits the individual needs and circumstances of your child, and to providing emotional and educational support for your entire family. We offer a variety of services to help you, your child and your family get through this difficult time.
Q: What kind of supportive or palliative care is available at Dana-Farber/Boston Children's?
A: When necessary, our Pediatric Advanced Care Team (PACT) is available to provide supportive treatments intended to optimize the quality of life and promote healing and comfort for children with life-threatening illness. In addition, PACT can provide psychosocial support and help arrange end-of-life care when necessary.
The first step in treating your child is forming an accurate and complete diagnosis, and the chances of treatment being successful are much higher if a brain tumor is caught early. Diagnostic procedures for brain tumors are used to determine the exact type of tumor your child has and whether the tumor has spread. These may include:
After we complete all necessary tests, our experts meet to review and discuss what they have learned about your child's condition. Then we will meet with you and your family to discuss the results and outline the best treatment options.
It’s entirely natural that you might be concerned, right now, about your child’s health; a diagnosis of a brain tumor can be frightening. But you can rest assured that, at Dana-Farber/Boston Children's, your child is in good hands. Our physicians are bright, compassionate, and committed to focusing on the whole child, not just his condition.
The good news is that treatment for brain tumors in children has progressed tremendously in the last decade:
Your child’s team will determine the best treatment plan based on a number of factors, including but not limited to:
Surgery has multiple roles in the diagnosis and treatment of brain tumors, including release of pressure on the brain, biopsy and tumor removal.
If your child has a brain tumor, the first treatment is usually surgery to remove as much of the tumor as possible.
Our doctors use precisely targeted and dosed radiation to kill cancer cells left behind after your child’s surgery. This is important to control the growth of the tumor. Depending on the type of the tumor, some patients are treated with targeted focal radiation therapy. In those tumors that may have spread, radiation therapy can sometimes be delivered to the entire brain and spine.
While radiotherapy can be quite effective in treating certain cancers, the radiation damages both cancerous and non-cancerous cells. Because of this, there can be many undesirable side effects during and after treatment. Being able to anticipate these side effects can help the care team, parents and child prepare, and, in some cases, prevent these symptoms from occurring.
Chemotherapy (“chemo”) refers to drugs that interfere with the cancer cell’s ability to grow or reproduce. For some kinds of tumors, chemotherapy before surgery may help shrink the tumor, making it possible to remove.
While chemotherapy can be quite effective in treating certain cancers, the drugs treat cancerous and non-cancerous cells the same. Because of this, there can be many undesirable side effects during treatment. Being able to anticipate these side effects can help the care team, parents and child prepare, and, in some cases, prevent these symptoms from occurring.
Chemotherapy is systemic treatment, meaning it is introduced to the bloodstream and travels throughout the body to kill cancer cells. It may be given:
Chemotherapy also refers to the use of drugs that are made to specifically inhibit a molecular pathway required to keep the tumor going. These drugs are often referred to as “targeted” therapy. Rather than the standard side effects associated with radiation and chemotherapy (loss of hair, nausea and vomiting, damage of the blood producing cells), these drugs tend to be much better tolerated.
As with other tumors in both children and adults, surgery is the primary treatment, usually followed by radiation treatment and/or chemotherapy. Unfortunately, because your child’s brain is still developing, these treatments can result in more substantial and permanent side effects than they would for an adult.
Many children who are treated for brain tumors experience significant long-term problems, such as changes in intellectual and motor function. They require ongoing assessment and specialized care to help them function at school and throughout life as best as possible.
Your child’s prognosis greatly depends on:
Today, more than half of all children diagnosed with a brain tumor will be cured of the disease. But with any cancer, prognosis and long-term survival varies greatly. Prompt medical attention and aggressive therapy are very important, as is continuous follow-up care.
Your child may also need a lot of rehabilitation for lost motor skill and muscle strength. If appropriate, he may also see speech therapists and physical and occupational therapists.
New methods are continually being discovered to improve treatment and to decrease side effects.
What kind of long-term follow-up care should my child get?
Because of the possible long-term problems and the risk of a tumor returning, assessments and care usually continue for years after the tumor is removed.
One of the major goals of the Dana-Farber/Boston Children's Pediatric Brain Tumor Program is to maximize the long-term function of your child. This is achieved through multidisciplinary monitoring and interventions, as needed, in a wide range of areas, including:
Through the Stop and Shop Neuro-Oncology Outcomes Clinic at Dana-Farber Cancer Institute, your child will be able to meet with his neurosurgeon, radiation oncologist, pediatric neuro-oncologist and neurologists at the same follow-up visit.
We understand that you may have a lot of questions if your child is diagnosed with a brain tumor. Will it affect my child long-term? What do we do next? We’ve tried to provide some answers to those questions in these pages, but there are also a number of resources and support services to help you and your family through this difficult time.
A Hopeful Future
Treatment for brain tumors in children has progressed tremendously in the last decade:
Research and clinical trials
Our program offers unique access to a range of brain tumor clinical trials in which your child can receive the newest brain tumor treatments. Through this research, our physicians work to improve current therapeutic approaches and outcomes for many hard-to-treat pediatric brain tumors.
Dana-Farber/Boston Children's oversees New England’s most active pediatric oncology clinical research program; it provides access to unique clinical trials for patients with newly diagnosed, relapsed or refractory brain tumors. We are:
Rapidly translating scientific discoveries to the bedside is a major focus of the program. Members of our brain tumor team:
Dramatic improvements in survival have been achieved for children and adolescents with cancer. Between 1975 and 2010, childhood cancer mortality decreased by more than 50%. Childhood and adolescent cancer survivors require close follow-up because cancer therapy side effects may persist or develop months or years after treatment. Refer to the PDQ summary on Late Effects of Treatment for Childhood Cancer for specific information about the incidence, type, and monitoring of late effects in childhood and adolescent cancer survivors.
Primary brain tumors are a diverse group of diseases that together constitute the most common solid tumor of childhood. Brain tumors are classified according to histology, but tumor location and extent of spread are also important factors that affect treatment and prognosis. Immunohistochemical analysis, cytogenetic and molecular genetic findings, and measures of proliferative activity are increasingly used in tumor diagnosis and classification.
Primary central nervous system tumors are a diverse group of diseases that together constitute
the most common solid tumor in childhood. The Central Brain Tumor Registry of the United States (CBTRUS) estimates that approximately 4,300 U.S. children are diagnosed each year.
Smith MA, Altekruse SF, Adamson PC, et al.: Declining childhood and adolescent cancer mortality. Cancer 120 (16): 2497-506, 2014.
Ostrom QT, Gittleman H, Farah P, et al.: CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol 15 (Suppl 2): ii1-56, 2013.
The classification of childhood central nervous system (CNS) tumors is based on histology and location. Tumors are classically categorized as infratentorial, supratentorial, parasellar, or spinal.
Immunohistochemical analysis, cytogenetic and molecular genetic findings, and measures of proliferative activity are increasingly used in tumor diagnosis and classification and will likely affect classification and nomenclature in the future.
Primary CNS spinal cord tumors comprise approximately 1% to 2% of all childhood CNS tumors. The classification of spinal cord tumors is based on histopathologic characteristics of the tumor and does not differ from that of primary brain tumors.
Infratentorial (posterior fossa) tumors include the following:
Supratentorial tumors include the following:
Parasellar tumors include the following:
Spinal cord tumors include the following:
Louis DN, Ohgaki H, Wiestler OD, et al., eds.: WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon, France: IARC Press, 2007.
Important concepts that should be understood by those treating and caring for a
child who has a brain tumor or spinal cord tumor include the following:
(Refer to the PDQ summary on Late Effects of Treatment for Childhood Cancer for more information about possible long-term or late effects.)
Fisher JL, Schwartzbaum JA, Wrensch M, et al.: Epidemiology of brain tumors. Neurol Clin 25 (4): 867-90, vii, 2007.
Blaney SM, Haas-Kogan D, Young Poussaint T, et al.: Gliomas, ependymomas, and other nonembryonal tumors of the central nervous system. In: Pizzo PA, Poplack DG, eds.: Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia, Pa: Lippincott Williams and Wilkins, 2011, pp 717-771.
Pollack IF: Brain tumors in children. N Engl J Med 331 (22): 1500-7, 1994.
Smith MA, Seibel NL, Altekruse SF, et al.: Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28 (15): 2625-34, 2010.
Reimers TS, Mortensen EL, Nysom K, et al.: Health-related quality of life in long-term survivors of childhood brain tumors. Pediatr Blood Cancer 53 (6): 1086-91, 2009.
Iuvone L, Peruzzi L, Colosimo C, et al.: Pretreatment neuropsychological deficits in children with brain tumors. Neuro Oncol 13 (5): 517-24, 2011.
Armstrong GT: Long-term survivors of childhood central nervous system malignancies: the experience of the Childhood Cancer Survivor Study. Eur J Paediatr Neurol 14 (4): 298-303, 2010.
Duffner PK, Horowitz ME, Krischer JP, et al.: Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328 (24): 1725-31, 1993.
Packer RJ, Lange B, Ater J, et al.: Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 11 (5): 850-6, 1993.
Mason WP, Grovas A, Halpern S, et al.: Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol 16 (1): 210-21, 1998.
Guidelines for the pediatric cancer center and role of such centers in diagnosis and treatment. American Academy of Pediatrics Section Statement Section on Hematology/Oncology. Pediatrics 99 (1): 139-41, 1997.
Presently, there is no uniformly accepted staging system for most childhood brain tumors. These tumors are classified and treated based on their histology and location within the brain (see Table below). However, with advances in molecular data, it is conceivable that genomic factors will refine classification approaches for certain groups of tumors, such as medulloblastomas  and low-grade gliomas.
Related PDQ Treatment Summary
Astrocytomas and Other Tumors of Glial Origin
– Low-Grade Astrocytomas
Diffuse fibrillary astrocytoma
Childhood Astrocytomas Treatment
Subependymal giant cell astrocytoma
– High-Grade Astrocytomas
Giant cell glioblastoma
Brain Stem Glioma
Diffuse intrinsic pontine glioma
Childhood Brain Stem Glioma Treatment
Focal or low-grade brain stem glioma
CNS Embryonal Tumors
Childhood CNS Embryonal Tumors Treatment
Medulloblastoma with extensive nodularity
– CNS Primitive Neuroectodermal Tumors (PNETs)
– Pineal Parenchymal Tumors
– CNS Atypical Teratoid/Rhabdoid Tumor
Childhood CNS Atypical Teratoid/Rhabdoid Tumor Treatment
CNS Germ Cell Tumors
Childhood CNS Germ Cell Tumors Treatment
Teratoma with malignant transformation
– Non-Germinomatous Germ Cell Tumors
Mixed germ cell tumor
Yolk sac tumor
Childhood Craniopharyngioma Treatment
Subependymoma (WHO Grade I)
Childhood Ependymoma Treatment
Myxopapillary ependymoma (WHO Grade I)
Ependymoma (WHO Grade II)
Anaplastic ependymoma (WHO Grade III)
Tumors of the Choroid Plexus
CNS = central nervous system; WHO = World Health Organization.
Recurrence is not uncommon in both low-grade and malignant childhood brain tumors and may occur many years after initial treatment. Disease may occur at the primary tumor site or, especially in malignant tumors, at noncontiguous central nervous system (CNS) sites. Systemic relapse is rare but may occur. At time of recurrence, a complete evaluation for extent of relapse is indicated for all malignant tumors and, at times, for lower-grade lesions. Biopsy or surgical re-resection may be necessary for confirmation of relapse; other entities, such as secondary tumor and treatment-related brain necrosis, may be clinically indistinguishable from tumor recurrence. The determination of the need for surgical intervention must be individualized based on the initial tumor type, the length of time between initial treatment and the reappearance of the lesion, and the clinical picture.
Early-phase therapeutic trials may be available for selected patients via Children's Oncology Group phase I institutions, the Pediatric Brain Tumor Consortium, or other entities.
Northcott PA, Shih DJ, Peacock J, et al.: Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488 (7409): 49-56, 2012.
Kool M, Korshunov A, Remke M, et al.: Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol 123 (4): 473-84, 2012.
Jones DT, Kocialkowski S, Liu L, et al.: Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68 (21): 8673-7, 2008.
Pfister S, Janzarik WG, Remke M, et al.: BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest 118 (5): 1739-49, 2008.
There is no uniformly accepted staging system for childhood primary spinal cord tumors. These tumors are classified and treated based on their location within the spinal cord and histology. Refer to the following PDQ summaries for more information on the staging and treatment of newly diagnosed and recurrent childhood spinal cord tumors:
This information is provided by the National Cancer Institute.
This information was last updated on August 12, 2014.
Many children with cancer receive treatment in the outpatient setting, which allows them to stay in school and continue to develop intellectually and socially. However, returning to school can be an emotional experience; our Back to School Program is designed to ease your child's transition back to the classroom.
Concierge Services is your one-stop place to learn about Dana-Farber programs, services and resources, as well as information on getting around Boston, finding lodging or restaurants, and activities in the area.
The Expressive Arts Therapy program, sponsored by the Leonard P. Zakim Center for Integrative Therapies, provides adult patients, family members, and caregivers with a variety of options to support well-being during cancer treatment. From live music meditation to painting technique workshops, the program offers a range of creative outlets to suit every interest.
Dana-Farber and Children's Hospital, including parking facilities, are fully accessible to people with disabilities. There are wheelchairs at the main entrance, and security staff can provide personal assistance. We also have many educational materials available in large print and audiotape formats.
The Ethics Consultation Service is available for patients and families who may be facing difficult decisions and choices regarding care. Our goal is to bring together patients, families and health care providers to talk about ethical concerns and help everyone involved arrive at a resolution that is right for all.
Find practical tips and suggestions for individuals caring for a family member or friend with cancer, including creating a caregiving plan, finding community resources, and looking after your own well-being.
Friends' Place provides personal consultations to help cancer patients of all ages cope with changes in physical appearance that result from cancer treatment. Our experienced, compassionate team provides fittings for compression garments or breast prostheses, helps with wigs and other head coverings, and offers make-up and skincare advice.
The Friends' Corner Gift Shop, located on the first floor of the Yawkey Center for Cancer Care, offers a wide selection of unique gifts and everyday items for patients, families and staff.
Every year, thousands of patients with cancer from around the world come to Dana-Farber for their care. We provide a wide array of logistical and other services for individuals who live outside the United States.
Dana-Farber provides interpreting services for patients whose first language is not English. Interpreters may be requested for any activity, including registration, booking appointments, attending treatments and exams, support groups, and meetings with doctors and other members of your health care team.
Just for Teens provides programs and activities for teens and young adults with cancer at the Jimmy Fund Clinic and Children's Hospital Boston. We offer activities and events both inside and out of the hospital so that you have creative ways to pass the time and can meet other teens who are going through similar experiences.
Our nutritionists are registered dietitians who can assist you in planning an optimal diet during any stage of your cancer journey, cope with any side effects you may experience, and answer your questions about the latest findings on cancer and nutrition.
The Eleanor and Maxwell Blum Patient and Family Resource Center and its satellite resource rooms are staffed by health care professionals and provide computer stations, books, brochures, videos, and CDs to help you find information and support on a variety of issues about cancer treatment and care.
Patients websites help friends and family members stay up-to-date on their loved ones' condition and write messages of support and encouragement.
The Dana-Farber pharmacy fills prescriptions for all pediatric and adult patients. Our pharmacists are an extension of the patient care team and work closely with your physicians to provide seamless, convenient, safe care.
More than 1,200 Dana-Farber patients and their families have enjoyed free trips to baseball games, theater shows, museums, and other attractions this year through the Recreational Resources program.
The School Liaison Program is for pediatric patients who are diagnosed with or have completed a treatment that involves the central nervous system. We provide consultation about the cognitive late effects of treatment to help parents understand and advocate for their child's learning needs.
Through all stages of cancer treatment and survivorship, our Spiritual Care staff is available 24 hours a day to provide emotional and spiritual support for adults and pediatric patients and family members.
Integrative therapies, also known as complementary therapies, range from acupuncture and massage to nutritional guidance and music therapy. Patients treated at the Zakim Center credit its services with easing nausea, improving circulation, and reducing pain, stress, and anxiety associated with cancer treatment.
Dr. Mark Kieran, Director of the Pediatric Brain Tumor Program, cares for children and teens with brain tumors. Dr. Kieran explains how explains how a multidisciplinary team of specialists come together to deliver specialized care for each child.
Learn more about how Dana-Farber/Children’s Hospital Cancer Center’s Pediatric Brain Tumor Program clinicians uniquely treat children and teens with brain and spinal cord tumors.
Browse clinical trials